Novel approaches to enable equitable access to monoclonal antibodies in low- and middle-income countries.
Monoclonal antibodies (mAbs) are revolutionizing management of non-communicable diseases in high-income countries and are increasingly being advanced for a range of infectious diseases (IDs). However, access to existing mAbs is limited in low- and middle-income countries (LMICs), and investment in d...
Saved in:
| Main Authors: | Shelly Malhotra, Anne-Isabelle Cameron, Dzintars Gotham, Esteban Burrone, Peter J Gardner, Colleen Loynachan, Sébastien Morin, Cherise P Scott, Carmen Pérez-Casas |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2024-01-01
|
| Series: | PLOS Global Public Health |
| Online Access: | https://journals.plos.org/globalpublichealth/article/file?id=10.1371/journal.pgph.0003418&type=printable |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The physiological limits of bispecific monoclonal antibody tissue targeting specificity
by: Armin Sepp, et al.
Published: (2025-12-01) -
Study on the monoclonal antibody to chlorpyrifos
by: JIN Ren-yao, et al.
Published: (2006-11-01) -
Monoclonal Antibodies to the Thyrotropin Receptor
by: Takao Ando, et al.
Published: (2005-01-01) -
Technological Advancements in Monoclonal Antibodies
by: José F. Santos-Neto, et al.
Published: (2021-01-01) -
Estimation of cost-based prices for injectable medicines in the WHO Essential Medicines List
by: Dzintars Gotham, et al.
Published: (2019-09-01)